Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

FY2021 Trading Update

2 Mar 2022 07:00

RNS Number : 2437D
Norman Broadbent PLC
02 March 2022
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

FY2021 Trading Update

Norman Broadbent (AIM: NBB) - a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services - provides the following unaudited trading update relating to the twelve months ended 31 December 2021.

The Board is pleased to provide the following update:

Highlights and Financial Information:

· Change in senior leadership team and Board appointments during H2. 

· New strategic plan in place focussed on accelerated, sustainable and profitable growth through acquisition and development of quality fee earning talent in the UK and internationally, combined with greater concentration on high margin Board and Executive Search business and a continually expanding Interim contractor book.

· Group Net Fee Income decreased slightly year-on-year by 5% to £5.9m (2020: £6.2m). However, following a challenging Q3, Q4 showed a very positive recovery as leadership changes and a renewed focus across the Group began to yield results, with £1.8m NFI, a 20% improvement on prior year Q4 (2020: £1.5m) and 38% increase on Q1 to Q3 average of £1.3m.

· Gross margin % increased to 89% (2020: 79%).

· Break even EBITDA for FY2021 (before exceptional restructuring costs).

· Continued selective overhead reductions combined with restructuring of the Senior Leadership and Leadership Consulting team, has reduced cash break-even point further prior to the recruitment of additional high quality and profit generating fee-earning talent.

· Q4 share issue by way of a subscription from major shareholders and senior leadership team raised circa £370k at a premium to support strategic restructuring.

· 2021 audit work commenced - Group anticipates releasing the full results for FY2021 in April 2022.

· 2022 hiring and growth strategy in execution phase. In 2022, to date 5 new fee earners have been secured with considerable further opportunities identified.

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"Having joined Norman Broadbent in September 2021, I have been incredibly impressed with the quality of the team and the shared commitment to our refreshed culture and exciting vision for the Group. This is demonstrated by a significant bounce back from a challenging Q3 (2021) to a very impressive and profitable Q4 performance. The momentum has continued into 2022 and, as our recruitment activities begin to yield results, we look forward to considerably strengthening and building the team in 2022 whilst also delivering positive EBITDA.

My optimism for the Group continues to grow. The quality of the established team, the work we have done over the past few months in refocussing the business, the standard and volume of new hires coming on board, the positive conditions prevailing across our diverse market sectors and the enduring strength of the Norman Broadbent brand all coalesce to create a very positive outlook. 

I am very enthusiastic about the future and would like to thank the team for their commitment to shaping and delivering positive change and delivering exceptional client outcomes. I would also like to thank all our clients (past, present and future) and our ever-supportive shareholders."

Peter Searle, Group Chair of Norman Broadbent, added:

"I am incredibly pleased that we are ahead of our strategic turnaround plan and that the business has continued to trade strongly after an excellent fourth quarter. We have a very capable management team in place who are now adding significant value to the Group."

Steve Smith, Group CFO/COO of Norman Broadbent, said

"It has been a pleasure to work alongside Peter and Kevin as they continue to inject a new level of strategic and operational expertise into the Group. In particular in the second half on 2021, we were able to reposition the business through leadership change and restructuring. We are now poised to accelerate growth in 2022 and beyond with a secure team and the renewed ability to attract and hire new fee earning talent of the highest quality. We continue to benefit from strong banking arrangements in place combined with supportive shareholders.

Looking ahead, we continue to seek growth opportunities and are actively pursuing M&A opportunities, long-term partnerships, and strategic 'tuck-ins'." 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information please contact:

Norman Broadbent plc

Kevin Davidson

Peter Searle

Steve Smith

 

+44 (0) 20 7484 0000

 

WH Ireland Limited

Jessica Cave

Darshan Patel

 

+44 (0) 20 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUASSRUAUORAR
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.